OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Clinical trial NCT03747458 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03747458
- Sponsor
- Optinose US Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2026-03-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.